Gan & Lee Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Gan & Lee Pharmaceuticals has a total shareholder equity of CN¥10.8B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥11.7B and CN¥877.4M respectively. Gan & Lee Pharmaceuticals's EBIT is CN¥164.6M making its interest coverage ratio -1.2. It has cash and short-term investments of CN¥4.9B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
Interest coverage ratio | -1.2x |
Cash | CN¥4.90b |
Equity | CN¥10.84b |
Total liabilities | CN¥877.36m |
Total assets | CN¥11.72b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 603087's short term assets (CN¥6.2B) exceed its short term liabilities (CN¥682.4M).
Long Term Liabilities: 603087's short term assets (CN¥6.2B) exceed its long term liabilities (CN¥195.0M).
Debt to Equity History and Analysis
Debt Level: 603087 is debt free.
Reducing Debt: 603087 had no debt 5 years ago.
Debt Coverage: 603087 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 603087 has no debt, therefore coverage of interest payments is not a concern.